Package Insert: Information for the Patient
Pantomicina 100mg/ml, Granulated for Oral Suspension
Eritromycin Etsylsuccinate
Read the entire package insert carefully before starting to take the medication, as it contains important information for you.
l
Pantomicina 100mg/ml contains erythromycin ethylsuccinate, an antibiotic that belongs to a group called macrolides.
Pantomicina 100mg/ml granulated for oral suspension is indicated for the treatment of:
Chlamydia trachomatis)
Pantomicina 100mg/ml is also used for the prevention of the following infections:
Do not take Pantomicina 500 mg
Warnings and precautions
Consult your doctor or pharmacist before starting to take Pantomicina 500 mg.
The repeated or prolonged use of erythromycin may cause resistance in bacteria or fungi. In this case, treatment should be interrupted and appropriate measures taken.
If you are taking Pantomicina to treat pneumonia, verify it with your doctor or pharmacist, as Pantomicina is not the reference treatment due to frequent resistance of the main pathogen. In this case, it will only be used in combination with other antibiotics.
Children and adolescents
If you are treating a young child and they are irritable or vomit when eating, contact your doctor immediately.
Use of Pantomicina 500 mg with other medications
Inform your doctor or pharmacist if you are using, have used recently, or may need to use any other medication, including over-the-counter medications.
It is especially important to inform them if you are taking any of the following medications and treatments.
The administration of Pantomicina 500 mg coated tablets may increase the effect of:
The following medications may reduce the effect of Pantomicina 500 mg coated tablets:
The administration of Pantomicina 500 mg coated tablets may decrease the effect of:
The use of Pantomicina 500 mg coated tablets with calcium channel blockers, such as verapamil, may cause low blood pressure, decreased heart rate, or acidification of the blood.
The use of Pantomicina 500 mg coated tablets with cimetidine (medication used for treating ulcers) may cause an increase in Pantomicina blood levels.
Use of Pantomicina 500 mg with food and beverages
Pantomicina 500 mg coated tablets can be taken before or after meals.
Pregnancy, lactation, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant or plan to become pregnant, consult your doctor or pharmacist before using this medication.
The active ingredient in Pantomicina 500 mg coated tablets may cross the placenta in pregnant women and be excreted in breast milk. The information from studies on the risk of congenital anomalies is not consistent, but some studies have reported heart abnormalities after the use of Pantomicina 500 mg coated tablets at the beginning of pregnancy.
Erythromycin should be used in women during pregnancy or lactation only if absolutely necessary.
Driving and operating machinery
Pantomicina has a mild effect on the ability to drive or operate machinery. If you experience symptoms such as dizziness or somnolence, do not drive or operate machinery.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
It is essential to follow the instructions related to the dose, administration schedule, and treatment duration prescribed by your doctor.
For oral use only.
The recommended dose is:
Adults and children over 8 years:10 ml or 20 ml per day divided into 3 or 4 doses is the usual dose. This dose may be increased up to 40 ml per day, depending on the severity of the infection.
Pediatric population
Children from 2 to 8 years:The usual dose is 2.5 ml twice a day.
Children under 2 years:The usual dose is 1.25 ml four times a day or 2.50 ml twice a day.
Geriatric patients
The same dose as for adults.
Patients with liver or kidney problems
Inform your doctor if you have kidney or liver problems, as your doctor may need to adjust the dose.
Treatment duration
The treatment duration depends on the individual and the type and severity of the infection. To be effective, this antibiotic should be used regularly at the prescribed doses and for the time indicated by your doctor. Do not stop taking this medication, even if you feel better, as early discontinuation of treatment may cause the infection to recur.
If you take more Pantomicina 100mg/ml than you should
The usual symptoms are nausea, vomiting, and diarrhea.
Treatment should be discontinued and supportive treatment initiated.
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
If you forget to take Pantomicina 100mg/ml
In case of a missed dose, take another as soon as possible. Then continue as directed. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Pantomicina 100 mg/ml
It is essential to complete the treatment cycle indicated by your doctor, even if you start feeling better after a few days. If you stop taking this medication before the indicated time by your doctor, it is possible that the infection may not have been fully cured and symptoms may recur or worsen.
Do not stop taking this medication without informing your doctor first.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Seek medical attention as soon as possible if you experience a severe skin reaction: a red, scaly rash with bumps under the skin and blisters (pustular exanthema). The frequency of this side effect is considered unknown (cannot be estimated from available data).
Some side effects can be serious. If you experience any of the following, stop taking the medicine and seek medical attention immediately:
Other side effects include:
Very common (may affect more than 1 in 10 people):
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people):
Very rare (may affect up to 1 in 10,000 people):
Frequency unknown(cannot be estimated from available data):
Additional side effects in children and adolescents:
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
This medication does not require special storage conditions.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or trash. Dispose of the containers and medications you no longer need at the SIGRE point of your pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medications you no longer need. By doing so, you will help protect the environment.
The active ingredient is erythromycin (in the form of ethylsuccinate).
Each tablet contains 500 mg of erythromycin (in the form of ethylsuccinate).
The other components are cornstarch, calcium dihydrogen phosphate, magnesium stearate, hypromellose, polyethylene glycol 400, titanium dioxide, carboxymethylcellulose sodium, povidone, yellow quinoline sorbic acid (CI=47005, E-104), polyethylene glycol 8000 (macrogol 8000), sorbic acid.
Ovate yellow tablet. Container of 30 tablets.
Amdipharm Limited
Temple Chambers
3 Burlington Road
Dublin 4,
Ireland
Ferrer Internacional, S.A.
Gran Vía Carlos III, 94
08028 – Barcelona
Spain
Responsible for manufacturing
Aesica Queenborough Limited
Whiteway Road (queenborough, Kent)
ME11 5EL – United Kingdom
Last review date of this leaflet: February 2023
The detailed and updated information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.